A Cannabigerol Derivative Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis

Phytocannabinoids that do not produce psychotropic effects are considered of special interest as novel therapeutic agents in CNS diseases. A cannabigerol quinone, the compound VCE-003, has been shown to alleviate symptoms in a viral model of multiple sclerosis (MS). Hence, we studied T cells and mac...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo-Salinas, Francisco J., Navarrete, Carmen, Mecha, Miriam, Feliú, Ana, Collado, Juan A., Cantarero, Irene, Bellido, María L., Muñoz, Eduardo, Guaza, Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
https://www.ncbi.nlm.nih.gov/pubmed/24727978
http://dx.doi.org/10.1371/journal.pone.0094733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984273/
https://www.ncbi.nlm.nih.gov/pubmed/24727978
http://dx.doi.org/10.1371/journal.pone.0094733

Ejemplares similares